The global multiple sclerosis drugs market to gain from development of economical therapy to treat multiple sclerosis (MS). Fortune Business Insights recently published a report, titled “Multiple Sclerosis Drugs: Global Market Analysis, Insights and Forecast, 2019-2026.” According to the report, the global market was worth US$ 23,460.3 Mn in 2018. The market is anticipated to expand at a CAGR of 6.7% and reach US$ 39,289.5 Mn by the end of 2026. The report offers a comprehensive overview of the global multiple sclerosis drugs market.
Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/multiple-sclerosis-drugs-market-100386
As per the report, North America emerged dominant in the global market in 2018. The region was valued at US$ 13,826.7 Mn in 2018. North America is anticipated to expand and continue dominate the market during the forecast period 2019-2026. The growth witnessed is attributable to the increasing demand and high price of multiple sclerosis drugs. Additionally, a lot key market players operate in the region and are expecting approval from the authority board for their newly developed therapeutics. This in response is expected to increase the growth rate in the global market. Europe is anticipated to stand second on the leading list by the end of 2026.
some of the key players in the global Multiple Sclerosis Drugs Market:
- Pfizer, Inc.
- Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/multiple-sclerosis-drugs-market-100386
The growth witnessed is attributable to increasing government spending and recommendations for multiple sclerosis treatment. This is expected to fuel the demand in the region. Besides this, Asia Pacific is anticipated to expand at the highest CAGR during the forecast period. Healthcare sector emerging in nations such as China and India is expected to contribute towards the Asia Pacific market expansion.
Tecfidera’s Increasing Sale to Drive Biogen’s Growth in Global Market
Biogen emerged as the leading player in the global multiple sclerosis market in 2018, owing to the high sales of Tecfidera. Biogen is expected to witness impressive growth during the forecast period by strategical partnering with other players to widen the distribution network. Besides this, Novartis AG is also among the leading organizations. Owing to high demand for Gilenya, Novartis holds a strong position in the global market. In 2018, the National Institute for Health and Care Excellence announced to recommend Extavia among other beta interferon drugs such as Avonex, Betaferon and Rebif. This is anticipated to contribute towards Novartis’s market position. Further, this is anticipated to fuel the demand for multiple sclerosis treatment and drugs. Some of the companies operating in the global market are Pfizer, Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Sanofi, and Teva Pharmaceutical Industries Ltd.
More Trending Topics from Fortune Business Insights:
Adult Malignant Glioma Therapeutics Market Size Worth US $2,964.5 Million at 9.3% CAGR Forecast till 2026
Blood Glucose Meters Market Share by Top Players to Worth USD 15.4 Billion by 2026 | Roche, Medtronic, Abbott, Sanofi and more
Dental Implants Market to Value US$ 5725.7 Mn at CAGR of 5.1% by 2026 | Exclusive Report by Fortune Business Insights
Ultrasound Equipment Market to Value US$ 10,500.8 Mn at CAGR of 5.1% by 2025 | Exclusive Report by Fortune Business Insights
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.